Roche
RO.SW
#40
Rank
NZ$602.55 B
Marketcap
NZ$756.24
Share price
0.56%
Change (1 day)
34.82%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$35.31

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$35.31. In 2025 the company made an earnings per share (EPS) of NZ$35.31 an increase over its 2024 EPS that were of NZ$19.87.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$35.3177.67%
2024NZ$19.87-32.84%
2023NZ$29.591.95%
2022NZ$29.02-6.29%
2021NZ$30.97-5.53%
2020NZ$32.7916.56%
2019NZ$28.1330.3%
2018NZ$21.5920.22%
2017NZ$17.95-5.81%
2016NZ$19.064.62%
2015NZ$18.22-5.13%
2014NZ$19.21-25.05%
2013NZ$25.6321.73%
2012NZ$21.053.82%
2011NZ$20.288.16%
2010NZ$18.7523.72%
2009NZ$15.15-12.31%
2008NZ$17.28-0.34%
2007NZ$17.3432.13%
2006NZ$13.1242.56%
2005NZ$9.20-22.7%
2004NZ$11.91132.85%
2003NZ$5.11-150.11%
2002NZ-$10.20-209.09%
2001NZ$9.35-57.03%
2000NZ$21.7753.29%
1999NZ$14.2031.24%
1998NZ$10.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.09-57.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.13-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.23-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.02-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.42-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$5.70-83.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.18-82.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.71-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK